University of Ljubljana
Also known as: Advanced Heart Failure and Transplantation Center, Universtiy Medical Center Ljubljana, Slovenia | Advanced Heart Failure and Transplantation Programme, University Medical Center Ljubljana, Slovenia | Brachytherapy Department, Institute of Oncology Ljubljana, Slovenia | CD of Anaesthesiology and Intensive Therapy, University Medical Centre Ljubljan | CD of Anaesthesiology and Intensive Therapy, University Medical Centre Ljubljana | CD of Neurosurgery, University Medical Centre Ljubljana | CLINICAL INSTITUTE OF CLINICAL CHEMISTRY AND BIOCHEMISTRY, University Medical Centre Ljubljana | David Drobne | Department of Endocrinology, Diabetes and Metabolic Diseases, Medical Center Ljubljana, Zaloska 7, 1525 Ljubljana, Slovenia | Department of Gynecology, Division of Gynecology and Obstetrics, Ljubljana University Medical Center | Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia | Department of Infectious Diseases, University Medical Centre Ljubljana, Slovenia | Department of Oral Medicine and Periodontology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia | Department of Otorhinolaryngology and Cervicofacial Surgery, UMC Ljubljana | Dep. of Cardiology, Uni. Medical Center Ljubljana, Slovenia | Dept. of Medical Oncology, Institute of Oncology Ljubljana, Slovenia | Dept. of Psychiatry and Psychotherapy; TU Dresden | Dept. of Radiation Oncology, Institute of Oncology Ljubljana, Slovenia | Division of Ob/Gyn, University Medical Centre Ljubljana, Slovenia | Dr Adolf Lukanovič | Faculty of Natural Science and Engineering, University of Ljubljana | General Hospital Murska Sobota; University of Ljubljana, Faculty of Medicine | General Hospital Murska Sobota; University of Ljubljana, Faculty of Sport | Institute of microbiology and immunology, Ljubljana, Slovenia | Institute of microbiology and immunology, Slovenia | Institute of mircobiology and immunology, Slovenia | Institute of Oncology Ljubljana | Institute of Oncology Ljubljana, Department of Surgical Oncology, Ljubljana, Slovenia | Institute of Oncology Ljubljana, Ljubljana, Slovenia | Institute of Oncology Ljubljana, Slovenia | Institute of Oncology, Ljubljana, Slovenia | Institute of Pharmacology and Experimental Toxicology, Medical Faculty, University Ljubljana | JKastrup | Ljubljana University | Marija Malgaj | Nephrology department, University Medical Centre Ljubljana, Slovenia | UCMLjubljana | UMC Ljubljana | UMC LJUBLJANA | UMC Ljubljana, Department of Infectious Diseases Ljubljana, Slovenia | UMCLjubljana, KOAIT | UMC Ljubljana Slovenia | University Eye Clinic Ljubljana | University Medical center, Hypertension Department - Ljubljana (Slovenia) | University Medical Center Ljubljana, Department of Gastroenterology | University Medical Center Ljubljana, Slovenia | University Medical Centre Ljubljana | University Medical Centre Ljubljana, Department of Nephrology | University Medical Centre Ljubljana, Department of Vascular Disease | University Medical Centre Ljubljana, Ljubljana, Slovenia | University Medical Centre Ljubljana (Slovenia) | University Medical Centre Ljubljana, Slovenia | University of Ljubljana | University of Ljubljana, Faculty of Medicine | University of Ljubljana, Faculty of Medicine, Institute of Pharmacology and Experimental Toxicology | University of Ljubljana, Faculty of Pharmacy | University of Ljubljana School of Medicine | University of Ljubljana School of Medicine, Slovenia
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2002Last known activity
Nov 1, 2025
Timeline
1910s
- Jan 1, 1919
University of Ljubljana— Founded
Drugs by trial phase (146 distinct, 152 trials)
Phase 4 (49 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Albuminuria
- Anemia
- Anemia, Iron-Deficiency
- Body Weight
- Carcinoma
- Carcinoma, Neuroendocrine
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Critical Illness
- Diabetes Complications
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Dysgeusia
- Dyslipidemias
- Dystonia
- Dystonic Disorders
- Erythema
- Erythema Chronicum Migrans
- Essential Hypertension
- Eunuchism
- Glaucoma, Open-Angle
- Glossitis, Benign Migratory
- Glucose Intolerance
- Head and Neck Neoplasms
- Heart Arrest
- Heart Diseases
- Helicobacter Infections
- Hyperparathyroidism
- Hyperparathyroidism, Primary
- Hypertension
- Hypogonadism
- Infarction
- Infections
- Infertility
- Infertility, Female
- Inflammation
- Insulin Resistance
- Liver Neoplasms
- Lyme Disease
- Mesothelioma
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms, Second Primary
- Neuralgia
- Non-ST Elevated Myocardial Infarction
- Obesity
- Ocular Hypertension
- Opioid-Related Disorders
- Osteoporosis
- Out-of-Hospital Cardiac Arrest
- Polycystic Ovary Syndrome
- Postoperative Pain
- Pre-Eclampsia
- Proteinuria
- Rectal Neoplasms
- Renal Insufficiency
- Sepsis
- Shock
- Shock, Septic
- ST Elevation Myocardial Infarction
- Thrombophlebitis
- Thrombosis
- Thyroid Diseases
- Thyroid Neoplasms
- Toxemia
- Ulcer
- Venous Thrombosis
- Weight Loss
Recent trials (50)
- NCT06923787Lead sponsorPhase 3Nov 1, 2025
- NCT07270549CollaboratorPhase 1/Phase 2Nov 1, 2025
- NCT07270549Sponsor investigatorPhase 1/Phase 2Nov 1, 2025
- NCT06923787OfficialPhase 3Nov 1, 2025
- NCT07178964OfficialN/AOct 1, 2025
- NCT07178964Sponsor investigatorN/AOct 1, 2025
- NCT07178964Lead sponsorN/AOct 1, 2025
- NCT07043686Sponsor investigatorN/AJun 13, 2025
- NCT07043686OfficialN/AJun 13, 2025
- NCT07043686Lead sponsorN/AJun 13, 2025
- NCT06893211Lead sponsorPhase 2Mar 18, 2025
- NCT07245069Sponsor investigatorPhase 2Feb 1, 2025
- NCT07245069Lead sponsorPhase 2Feb 1, 2025
- NCT06794385Lead sponsorPhase 4Jan 22, 2025
- NCT06785831CollaboratorN/AJan 20, 2025
Details
- Founded
- Ljubljana, SI Jan 1, 1919
- Last known activity
- Nov 1, 2025